Afalase, tablets 100 pcs

Pharmacodynamics

It was shown experimentally and clinically that antibodies to prostate-specific antigen (PSA) affinity purified modify the functional activity of endogenous PSA, altered in benign prostatic hyperplasia, which is accompanied by strengthening of the regulatory effect of this antigen on functional and metabolic processes in the prostate tissue, have a pronounced anti-inflammatory and anti-edema effect.

Antibodies to endothelial NO-synthase affinity purified promotes an increase in the rate of blood flow, including in the vessels of the penis and prostate, has a protective effect in relation to the endothelium (helps reduce vascular reactivity, decrease
vascular spasm and improve peripheral microcirculation).

The combined use of the components in the complex preparation “Afalase” is accompanied by a synergetic effect: antibodies to endothelial NO-synthase increase antiproliferative and anti-inflammatory activity of antibodies to PSA due to their endothelioprotective effect and improvement of vascularization. The synergistic effect is probably also due to nonspecific
mechanisms of enhancing intracellular signal transduction by dilutions of antibodies to endothelial NO synthase.

In patients with benign prostatic hyperplasia (BPH) the preparation if used for 12 months facilitates the reduction of the prostate volume, improvement of urodynamic parameters (decrease of residual urine volume, increase of maximum urine velocity), significant decrease of dysuric disorders severity without affecting PSA level. The drug improves quality of life of patients with BPH.

Pharmacokinetics

The sensitivity of modern physico-chemical methods of analysis (gas-liquid chromatography, high-performance liquid chromatography, chromatography-mass spectrometry) does not allow to estimate the content of active substances of the drug Afalase in biological fluids, organs and tissues, which makes it technically impossible to study pharmacokinetics.

Indications

Prostatitis, Erectile dysfunction, Urinary disordersAphalase is indicated for use in adults.

Benign prostatic hyperplasia.

Dysuric disorders (as part of complex therapy): frequent urges to urination, difficulty in urination, pain and discomfort in the perineum.

Active ingredient

Antibodies

Composition

Active ingredients:

Antibodies to endothelial NO-synthase affinity purified – 0.006 g*,

Antibodies to prostate-specific antigen affinity purified – 0.006 g*.

Excipients: lactose monohydrate, microcrystalline cellulose, magnesium stearate.

* Applied on lactose monohydrate as a mixture of three active water-alcohol dilutions of the substance, diluted respectively 10012, 10030, 100200 times.

How to take, the dosage

Inside. It is recommended to take the preparation in the morning and in the evening (keep it in the mouth until dissolving completely – after meals).

In case of dysuric disorders it is recommended to take the preparation during 16 weeks.

It is recommended to take the preparation up to 4 times a day during the first 2-3 weeks of therapy if the pain syndrome and dysuric disturbances are marked.

In order to prevent the growth of the prostate gland in patients with BPH and to reduce the risk of disease progression it is recommended to take the preparation twice a day, in the morning and in the evening during 12 months.

Interaction

Incompatibilities with other drugs have not yet been registered.

Special Instructions

The drug contains lactose monohydrate; therefore, it is not recommended for patients with congenital galactosemia, glucose malabsorption syndrome or congenital lactase deficiency.

Synopsis

The tablets are flat and cylindrical, rimmed and beveled, white to almost white. The flat side with a rib is labeled MATERIA MEDICA, the other flat side is labeled AFALAZA.

Contraindications

Increased individual sensitivity to the drug components.

Age under 18 years.

Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

Side effects

Possible reactions of individual hypersensitivity to the components of the drug.

.

Overdose

In an accidental overdose, dyspepsia is possible due to the excipients in the drug.

Pregnancy use

The drug Afalaza is not intended for use in women.

Similarities

Proproten-100, Anaferon, Tenoten, Afala, Colophort, Regaline, Impaza, Artrofon, Divase, Tenoten for children, Anaferon for children